SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is trending due to a sharp pullback following the announcement of a 75-million share offering intended to fund capital contributions for its Georgia facility, which has overshadowed positive Q2 revenue guidance. Community sentiment is deeply divided between long-term investors who view the dilution as a necessary strategic move to unlock federal loan funding and retail traders expressing frustration over the timing and perceived impact on short-term price momentum.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Biocryst Pharmaceuticals is gaining momentum as investors pivot toward the company following news of its strategic shift to close internal discovery facilities, fueling community speculation about a potential buyout or M&A activity. Market participants are actively discussing the stock's improved capital efficiency and pipeline potential while monitoring heavy volume and unusual options activity for signs of a breakout.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is gaining significant momentum as investors anticipate key clinical milestones and weigh the potential for a strategic partnership or buyout within the high-growth obesity drug sector. The community is intensely focused on the upcoming maintenance study results, which many view as a critical catalyst for the stock's valuation, while simultaneously debating the aggressive short interest and the company's long-term independence.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is currently trending as investors grapple with extreme volatility and a broader semiconductor sell-off driven by concerns over the sustainability of the AI-led growth cycle. Community sentiment remains deeply divided, with many traders debating whether the stock's recent sharp pullback is an institutional shakeout and buying opportunity or a signal of a deeper structural correction for the chip sector.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

United States Oil Fund is trending as renewed military strikes in the Strait of Hormuz disrupt global energy shipping, forcing investors to weigh heightened geopolitical risk against attempts by officials to manage supply concerns. The community is actively debating the durability of the current maritime truce and whether ongoing infrastructure attacks will cause a sustained supply squeeze despite recent downward price pressure.

American Bitcoin Corp. engages in the management of a bitcoin accumulation platform. It offers exposure to bitcoin through an industry-first business model that integrates scaled self-mining operations with disciplined accumulation strategies. The company was founded by Eric Trump and Donald John Trump Jr. on October 3, 2018 and is headquartered in Miami, FL.

American Bitcoin Corp. - Ordinary Shares - Class A

American Bitcoin Corp.

American Bitcoin Corp. (ABTC) is facing significant investor backlash as shareholders weigh the impact of an approved reverse stock split against ongoing concerns over extreme dilution and the company's association with the Trump family. The community is sharply divided, with some investors aggressively accumulating shares in hopes of a technical rebound or sector-wide crypto rally, while others are calling for regulatory investigations and labeling the stock a failed pump-and-dump scheme.

Penguin Solutions, Inc. engages in designing, building, and managing enterprise solutions. It operates through the following segments: Advanced Computing, Integrated Memory, and Optimized LED. The Advanced Computing segment offers platform solutions and services for artificial intelligence, high-performance computing, machine learning, advanced modeling, and the internet of things. The Integrated Memory refers to integrated memory solutions through the design and development. The Optimized LED segment comprises a broad portfolio of application-optimized LEDs. The company was founded in 1988 and is headquartered in Fremont, CA.

Penguin Solutions Inc.

Penguin Solutions is surging as investors closely monitor its role in AI infrastructure, specifically highlighting its CXL memory technology and status as an NVIDIA AI Factory Specialized Partner. The community is actively debating the stock's long-term valuation potential while navigating significant volatility ahead of the upcoming earnings report.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded by Keyvan Mohajer, Majid Seyed Emami and James M. Hom on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is drawing intense community focus due to a volatile battle between bulls targeting a short squeeze and shorts attempting to defend the $7.00 resistance level. Investors are heavily weighing the stock's high short interest and recent merger-related news against concerns regarding ongoing volatility and management's future performance.

Joby Aviation, Inc. is a transportation company, which engages in developing an all-electric, vertical take-off and landing aircraft that intends to operate as a commercial passenger aircraft. The company was founded by Bevirt Joebenn in 2009 and is headquartered in Santa Cruz, CA.

Joby Aviation Inc

Joby Aviation is attracting significant attention as investors react to the launch of a majority-owned joint venture with Toyota, aimed at scaling commercial eVTOL production. While bulls emphasize this manufacturing alliance and progress in FAA certification as key long-term catalysts, the stock continues to experience high volatility and intense short-interest, sparking active community debates between those anticipating a major breakout and those concerned about ongoing cash burn and dilution.

T1 Energy, Inc. engages in providing energy solutions focused on solar module and solar cell manufacturing. It focuses on building an integrated U.S. supply chain for solar and batteries. The company was founded by Tom Einar Jensen, Peter Matrai, and Tore Ivar Slettemoen on August 31, 2023 and is headquartered in Austin, TX.

T1 Energy Inc.

T1 Energy Inc. is trending as investors weigh an Intertek CEA 'A' grade audit, which supports its bankability as a domestic solar manufacturer, against ongoing volatility driven by earlier short-seller allegations. The community is heavily focused on the company's long-term potential as an AI infrastructure and energy storage play, with many actively accumulating shares during price dips while waiting for updates on G2 facility funding.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Stocks making the biggest moves midday: SpaceX, GE Vernova, Crinetics Pharmaceuticals, Rivian & more

Here are some of the companies making headlines in midday trading...

12 Health Care Stocks Moving In Tuesday's Intraday Session

Gainers

Crinetics Pharmaceuticals (NASDAQ:CRNX) shares moved upwards by 98.7% to $83.53 during Tuesday's regular session. The company's market cap stands at $4.4 billion.
Tvardi Therapeutics (NASDAQ:TVRD)read more...

Tuesday Sector Leaders: Drugs, Gas Utilities

In trading on Tuesday, drugs shares were relative leaders, up on the day by about 2%. Leading the group were shares of Crinetics Pharmaceuticals, up about 98.8% and shares of Pyxis Oncology up about 18.7% on the day.

Also showing relative strength are gas utilities shares, up...

Crinetics Acquisition Creates A ‘Fifth Commercial Pillar’ For Vertex, Says Analyst – Why HC Wainwright Sees A 24% Upside Potential In VRTX Stock  

Equity

H.C. Wainwright said Crinetics’ lead product Palsonify adds a meaningful commercial product and establishes endocrinology as Vertex’s fifth major business pillar.

VRTX to Strengthen Rare Disease Portfolio With $10B Crinetics Buyout 

Vertex to acquire CRNX for $10B, adding approved rare disease drug Palsonify and late-stage pipeline assets to expand its endocrinology portfolio.

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Gainers

Crinetics Pharmaceuticals (NASDAQ:CRNX) stock increased by 98.9% to $83.59 during Tuesday's pre-market session. The market value of their outstanding shares is at $4.4 billion.
Bluejay Diagnosticsread more...

Stocks making the biggest moves premarket: Fiserv, Crinetics Pharmaceuticals, Micron & more

These are the stocks posting the largest moves in early trading...

Why Crinetics Pharmaceuticals Shares Are Trading Higher By 99%; Here Are 20 Stocks Moving Premarket

Crinetics Pharmaceuticals Inc (NASDAQ: CRNX) rose in pre-market trading after being acquired by Vertex Pharmaceuticals (NASDAQ: VRTX) for $85/share.read more...

SLS Stock Rises Overnight: Why Retail Traders Prefer Sellas Over IBRX, ONDS, PYPL As Most Bullish Pick

Traders are watching for the 80th event, data lock and topline results, while some are also speculating about potential M&A.

CRNX Stock Soars Nearly 100% After-Hours On Vertex's $10B Acquisition

The deal values Crinetics at $85 per share in cash, representing a potential upside of about 100% from the stock’s closing price on Monday.


Crinetics Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. The firm's product candidate, CRN00808, is an oral nonpeptide somatostatin agonist for the treatment of acromegaly. It is also developing other oral nonpeptide somatostatin agonists for neuroendocrine tumors and hyperinsulinism, as well as an oral nonpeptide ACTH antagonist for the treatment of Cushing's disease. The company was founded by R. Scott Struthers, Yun-Fei Zhu and Stephen F. Betz in 2008 and is headquartered in San Diego, CA.

Crinetics Pharmaceuticals Inc

Extremely Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Stocktwits

Stocktwits Polls

The stock soared nearly 100% after the announcement of a definitive $10 billion all-cash acquisition deal at $85 per share.

Investors are optimistic that recent M&A activity and industry premium valuations are fueling a broader bull run across the entire sector.

Traders are actively speculating on which clinical-stage biotech stocks might be the next candidates for high-premium acquisition deals.

Current Price	$83.51
Prev Close	$42.03
Open	$83.58
Dividend Yield	0.00%
50-Day Moving Average	$36.84
Beta	1.18
Avg. Volume	1.24M
PE Ratio	-8.19

52-Week High	$57.99
52-Week Low	$25.83
Market Capitalization	$4.43B
EPS (Annual)	-$4.95
Price to Book	3.46
Revenue Per Employee	$12,956.23

Feed

News

Sentiment

Earnings

Fundamentals

Info

CRNXCrinetics Pharmaceuticals Inc

Latest CRNX News